Cargando…
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats
Repaglinide (RPG), a monotherapy insulin secretagogue used to treat diabetes mellitus-type II yet, it suffers from poor water solubility and variable bioavailability (∼ 50%) due to hepatic first pass metabolism. In this study, 2FI I-Optimal statistical design was employed to encapsulate RPG into nio...
Autores principales: | Fouad, Shahinaze A., Teaima, Mahmoud H., Gebril, Mostafa I., Abd Allah, Fathy I., El-Nabarawi, Mohamed A., Elhabal, Sammar Fathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943253/ https://www.ncbi.nlm.nih.gov/pubmed/36803255 http://dx.doi.org/10.1080/10717544.2023.2181747 |
Ejemplares similares
-
Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
por: Abdelmonem, Rehab, et al.
Publicado: (2021) -
Merging konjac glucomannan with other copolymeric hydrogels as a cutting-edge liquid raft system for dual delivery of etoricoxib and famotidine
por: Shoman, Nabil A., et al.
Publicado: (2023) -
Evaluation and Comparison of Three Types of Spray Dried Coprocessed Excipient Avicel® for Direct Compression
por: Vodáčková, Pavlína, et al.
Publicado: (2018) -
A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study
por: Teaima, Mahmoud H, et al.
Publicado: (2021) -
Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters
por: Dhakal, Bhawana, et al.
Publicado: (2022)